Summary
Upon incubation of hepatocyte isolated from rats with secretin at concentration ranging from 0.1 unit to 1.0 unit per ml, glycogenolysis was maximally stimulated after 15 min. Somatostatin inhibited liver glycogenolysis. The combined addition to the incubation medium showed that somatostatin inhibited the stimulated glycogenolysis induced by secretin, while secretin plus vasoactive intestinal peptide showed no additive effects on glycogenolysis, as compared with single addition of secretin. However, the addition of glucagon to secretin showed additive effects on glycogenolysis.
These results suggest that the receptor site for secretin might be different from that for glucagon, but the same as that for vasoactive intestinal peptide. Moreover, the calcium ion was shown to be a prerequisite for the inducible effects of the hormones so far tested.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mutt V, Jorpes JE: Secretin-Isolation and determination of structure. Proceedings of the Fourth International Symposium on the Chemistry of Natural Products, Stockholm, Sweden, 1966
Grossman MI: Endocrinology of the Gut (chey WY, Brooks FP, eds.) pp 66, 1974
Endocrinology, Editors Yoshimura F, Kawakami M, Imura H, Tojo S. Nanzando Company, Limited Tokyo. 1213, 1976.
Unger RH, Ketterer H., Dipre J., Eisentraut AM: Effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anaesthetized dogs. J Clin Invest 46: 630, 1967
Desbuquois B., Laudat MH, Ph Laudat: Vasoactive intestinal polypeptide and glucagon: stimulation of adenylate cyclase activity via distinct receptors in liver and fat cell membranes. Biochem Biophys Res Commun 53: 1187, 1973
Bataille D., Freychet P., Rosselin G.: Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes: binding to specific sites and stimulation of adenylate cyclase. Endocrinology 95: 713, 1974
Matsumura M., Akiyoshi H., Saito S., Mori H.: Effects of vasoactive intestinal peptide on glycogenolysis in cultured liver cells. Endocrinol Japon 26: 233, 1979
Berry MN, Friend DS: High yield preparation of isolated rat liver parenchymal cells. J Cell Biol 43: 506, 1969
Devis G., Somers G., Van Obberghen E., Malaisse WJ: Calcium antagonists and islet function I. Inhibition of insulin release by Verapamil. Diabetes 24: 547, 1975
Trimble ER, Buckanan KD, Hadden DR, Montgomery DAD: Secretin: High plasma levels in diabetes mellitus. Acta Endocrinol 85: 799, 1977
Arimura A.: Recent progress in research of somatostatin. Clinical Endocrinology 26: 520, 1978
Malaisse WJ: Insulin secretion: Multifactorial regulation for a single process of release. Diabetologia 9: 167, 1973
Robberecht P., Deschodt-Lanckman M. Philippe de Neef, Christophe J: Effects of somatostatin on pancreatic exocrine function. Interaction with secretin. Biochem Biophys Res Commun 67: 315, 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsumura, M., Akiyoshi, H. Effects of secretin on glycogenolysis in cultured liver cells. Gastroenterol Jpn 15, 221–225 (1980). https://doi.org/10.1007/BF02774271
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02774271